President and CEO of BioMimetic Therapeutics Inc. (BMTI, Financial) Samuel Eugene Lynch sells 3,000 shares of BMTI on 07/30/2009 at an average price of $10.09 a share.
BioMimetic Therapeutics Inc. has a market cap of $200.2 million; its shares were traded at around $10.17 with and P/S ratio of 63.5.
Recent Trades of BioMimetic Therapeutics Inc. by CEO:
Recent Trades of BioMimetic Therapeutics Inc. by CFO:
Recent Trades of BioMimetic Therapeutics Inc. by Directors and Officers:
BioMimetic Therapeutics Inc. has a market cap of $200.2 million; its shares were traded at around $10.17 with and P/S ratio of 63.5.
Recent Trades of BioMimetic Therapeutics Inc. by CEO:
- Sell: President and CEO Samuel Eugene Lynch sold 3,000 shares of BMTI stock on 07/29/2009 at the average price of $9.84; the price of the stock has increased by 3.35% since.
- Sell: President and CEO Samuel Eugene Lynch sold 3,000 more shares of BMTI stock on 07/17/2009 at the average price of $9.8; the price of the stock has increased by 3.78% since.
- Sell: President and CEO Samuel Eugene Lynch sold 3,000 more shares of BMTI stock on 07/16/2009 at the average price of $9.87; the price of the stock has increased by 3.04% since.
- Sell: President and CEO Samuel Eugene Lynch sold 3,000 more shares of BMTI stock on 07/01/2009 at the average price of $9.36; the price of the stock has increased by 8.65% since.
- Sell: President and CEO Samuel Eugene Lynch sold 3,000 more shares of BMTI stock on 06/30/2009 at the average price of $9.26; the price of the stock has increased by 9.83% since.
Recent Trades of BioMimetic Therapeutics Inc. by CFO:
- Buy: CFO Lawrence E Bullock bought 6,000 shares of BMTI stock on 04/01/2009 at the average price of $6.8; the price of the stock has increased by 49.56% since.
Recent Trades of BioMimetic Therapeutics Inc. by Directors and Officers:
- Buy: Director James G Murphy bought 508 shares of BMTI stock on 06/25/2009 at the average price of $8.5; the price of the stock has increased by 19.65% since.
- Buy: 10% Owner A/s Novo bought 343,406 shares of BMTI stock on 06/25/2009 at the average price of $8.5; the price of the stock has increased by 19.65% since.
- Buy: Director Gary E Friedlaender bought 8,174 shares of BMTI stock on 06/25/2009 at the average price of $8.5; the price of the stock has increased by 19.65% since.
- Buy: Director Christopher B Ehrlich bought 941,177 shares of BMTI stock on 04/07/2009 at the average price of $8.5; the price of the stock has increased by 19.65% since.
- Sell: General Counsel Earl Martin Douglas sold 1,200 shares of BMTI stock on 03/17/2009 at the average price of $8.45; the price of the stock has increased by 20.36% since.
